PERSPECTA

News from every angle

← Back to headlines

A high dose of Wegovy helped people lose 21% of their weight. It was just approved.

Novo Nordisk’s 7.2 mg dose of Wegovy will compete against Lilly’s GLP-1 injection.

19 Mar, 18:42 — 19 Mar, 18:42
PostShare

Sources

Showing 1 of 1 sources
marketwatchMostly Factual1h ago

A high dose of Wegovy helped people lose 21% of their weight. It was just approved.

Novo Nordisk’s 7.2 mg dose of Wegovy will compete against Lilly’s GLP-1 injection.

By Jaimy Lee

Read full article →

Related Stories

Kebbi probes death of two children in hospital

just now

Relmada Therapeutics GAAP EPS of -$0.27 misses by $0.13

19m ago

Curis GAAP EPS of $1.23 beats by $1.67, revenue of $1.14M misses by $2.11M

21m ago

FDA backs off stricter tanning bed rules with RFK Jr.'s support

22m ago